The startup's first test focuses on diagnosing 60 conditions for which treatment is available.
Michigan Radio reports that a parent there has filed a lawsuit over its newborn screening program.
At the ACMG meeting, Cynthia Morton said that several projects, including her team’s SEQaBOO study, are exploring the utility of genomic testing in newborn hearing screening.
Victorian Clinical Genetics Services is one of two partners in Acute Care Genomics, which is testing DNA from critically ill infants and kids across Australia.
The $649 NGS test screens for 193 disorders, can be ordered online, and is designed to supplement standard state newborn screening services.
Sema4 announces a new test to look for more diseases among newborn's genes, Technology Review reports.
The so-called ACT sheets are one pagers that guide doctors on what to do after receiving a genetic test results for a patient.
Parents are lobbying for more states to add adrenoleukodystrophy to newborn genetic screening tests, NPR reports.
Last week, the company launched whole-genome sequencing of children for customers of its ViaCord cord blood and tissue banking business.
The investment bank, which maintained its $60 price target for the company's stock, said it is looking for signs of revenue acceleration.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.